首页> 外文期刊>Immunologic Research: A Selective Reference to Current Research and Practice >Myeloid derived suppressor cells in physiological and pathological conditions: The good, the bad, and the ugly
【24h】

Myeloid derived suppressor cells in physiological and pathological conditions: The good, the bad, and the ugly

机译:在生理和病理条件下源自髓样的抑制细胞:好,坏和丑陋

获取原文
获取原文并翻译 | 示例
       

摘要

Myeloid derived suppressor cells (MDSCs), a heterogeneous population of myeloid progenitors, are recognized as a key element in tumor escape and progression the importance of MDSCs in human malignancies has been demonstrated in recent years, and new approaches targeting their suppressive/tolerogenic action are currently being tested in both preclinical model and clinical trials. However, emerging evidence suggests that MDSCs may play a prominent role as regulator of the physiologic, the chronic, and the pathologic immune responses. This review will focus on the biology of MDSC in light of these new findings and the possible role of this myeloid population not only in the progression of the tumor but also in its initiation.
机译:髓样来源的抑制细胞(MDSC)是髓样祖细胞的异质群体,被认为是肿瘤逃逸和进展的关键因素,近年来已经证明了MDSC在人类恶性肿瘤中的重要性,针对其抑制/致耐受作用的新方法是目前正在临床前模型和临床试验中进行测试。但是,越来越多的证据表明,MDSCs可以作为生理,慢性和病理免疫反应的调节剂发挥重要作用。鉴于这些新发现以及骨髓瘤群体不仅在肿瘤的进展中而且在其发生中的可能作用,本文将重点关注MDSC的生物学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号